|
|
Other links at Articles > Cardiology |
| 1. |
No SEISMIC Shift in Outlook for Stem Cell Therapy
|
|
|
Yet another trial of stem cell therapy has failed to deliver any significant results. The phase 1/2 SEISMIC study reported last week did not show any evidence of efficacy with MyoCell skeletal myoblast cell therapy in post-MI heart failure, although the procedure appeared safe. More trials are needed to demonstrate clinical value, experts said. Heartwire
|
| 3. |
Study Data Link 2 NRTIs to Increased MI Risk
|
|
|
The FDA recommends that healthcare professionals discuss potential risks and benefits of abacavir (Ziagen) and didanosine (Videx) therapy, including myocardial infarction, with HIV-infected patients. Medscape Medical News
|
| 5. |
Genomic Ties to Dyslipidemia
|
|
|
Dr. Samir Damani discusses 3 important papers in regard to the relationships of multiple genetic markers to dyslipidemia.
Medscape Genomic Medicine
|
|
|